Citi lowered the firm’s price target on QuidelOrtho (QDEL) to $40 from $50 and keeps a Buy rating on the shares. The firm views the company’s Q2 report and cost actions planned for the back of half of 2025 positively.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: